Serdar E. Bulun

ORCID: 0000-0003-0850-8637 · 134 papers in corpus
other 2000
American journal of obstetrics and gynecology ·doi:10.1016/s0002-9378(00)70325-5

OBJECTIVE: Although an association between dioxin exposure and endometriosis has been proposed, the effects of this environmental toxin on human endometriosis are not known. To understand the potential underlying molecular mechanisms we stu…

2000
·doi:10.1210/jcem.85.8.6739

We previously demonstrated that 17β hydroxysteroid dehydrogenase type 2, the enzyme that inactivates estradiol to estrone, is expressed in luteal eutopic endometrium in response to progesterone but not in simultaneously biopsied peritoneal …

review 1999
Fertility and sterility ·doi:10.1016/s0015-0282(99)00393-3

OBJECTIVE: To provide a clinically useful model illustrating the molecular aberrations affecting estrogen biosynthesis and metabolism in endometriosis and to discuss the therapeutic role of aromatase inhibitors. DESIGN: Literature review. …

review 1999
Endocrine-related cancer ·doi:10.1677/erc.0.0060293

Estrogen is the most important known factor that stimulates the growth of endometriosis. Estrogen delivery to endometriotic implants was classically viewed to be only via the circulating blood in an endocrine fashion. We recently uncovered …

lab-animal 1999
Molecular Endocrinology ·doi:10.1210/mend.13.2.0229

In stromal cells of endometriosis, marked levels of aromatase P450 (P450arom) mRNA and activity are present and can be vigorously stimulated by (Bu)2cAMP or PGE2 to give rise to physiologically significant estrogen biosynthesis. Since eutop…

other 1998
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem.83.12.5301

Aberrant aromatase expression in stromal cells of endometriosis gives rise to conversion of circulating androstenedione to estrone in this tissue, whereas aromatase expression is absent in the eutopic endometrium. In this study, we initiall…

case-report 1998
Fertility and sterility ·doi:10.1016/s0015-0282(98)00022-3

OBJECTIVE: To treat an unusually aggressive case of recurrent postmenopausal endometriosis. DESIGN: Case report. SETTING: University of Texas Southwestern Medical Center (Dallas, Texas). PATIENT(S): A 57-year-old woman who presented with…

lab-animal 1997
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem.82.2.3783

C19 steroids are converted to estrogens by aromatase P450 (P450arom). Aromatase expression in humans is regulated by use of tissue-specific promoters in the placenta (promoter I.1), adipose tissue (promoters I.4, I.3, and II), and gonads (p…

other 1996
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem.81.1.8550748

The conversion of C19 steroids to estrogens occurs in a number of tissues, such as the ovary and placenta, and is catalyzed by aromatase P450 (P450arom; the product of the CYP19 gene). P450arom expression has also been detected in a number …